Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Leading experts treating COVID-19 patients provide advice on managing cardiovascular disease during the pandemic. The European Society of Cardiology (ESC) guidance is published online.1
The novel coronavirus not only causes viral pneumonia but also has major implications for the cardiovascular system.
Heart and stroke patients are more likely to have severe cases of COVID-19, as are people with other risk factors, including advanced age, diabetes, hypertension and obesity.
In addition, COVID-19 patients may develop heart damage, which raises their chance of dying.
This detailed document provides healthcare professionals the best available knowledge, based on practical experience, on how to diagnose and manage cardiovascular conditions in COVID-19 patients, treat the coronavirus infection, and organise and prioritise care. It will be updated as more evidence is gathered.
Authors: ESC Press Office Tel: +33 (0)4 89 87 20 85
Mobile: +33 (0)7 8531 2036 Email: email@example.com
Follow us on Twitter @ESCardioNews
12020 ESC Guidance for the Diagnosis and Management of CV Disease in the Context of the COVID-19 Pandemic
For the latest science on COVID-19 and heart disease visit the ESC’s dedicated web page: COVID-19 and Cardiology.
Follow us on Twitter @ESCardioNews to hear when new material is published.
See COVID-19 and Heart Patients Q&A here.
About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.